Abstract
Radioiodine therapy is often required after thyroidectomy for the treatment of thyroid cervical debris and metastases from Differentiated Thyroid Carcinoma (DTC). About 25% of the administered dose of iodotherapy with I131 is eliminated in the saliva, which may compromise the salivary glands, causing discomfort due to xerostomia and compromising oral health. The objective of this study is…